James Fulmer
Precision Therapeutics (United States)(US)Eisai (United States)(US)
Publications by Year
Research Areas
Pancreatic function and diabetes, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Cardiac Valve Diseases and Treatments, Orthopaedic implants and arthroplasty
Most-Cited Works
- → The initiation of liver development is dependent on Foxa transcription factors(2005)588 cited
- → The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trial(2014)264 cited
- → The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion(2005)210 cited
- → Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors(2023)140 cited
- → A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease(2019)51 cited
- → Fenfluramine Disrupts the Mitral Valve Interstitial Cell Response to Serotonin(2009)51 cited
- → Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate(2006)49 cited
- → Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature(2015)46 cited
- → Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models(2021)34 cited